MedPath

Medgenics Medical (Israel) Ltd.

🇮🇱Israel
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Epodure Therapy of Anemia in End Stage Renal Disease on Dialysis With Epodure Skin Implant

Phase 1
Terminated
Conditions
Anemia
End Stage Renal Disease
Interventions
Procedure: implantation of autologous skin graft after ex-vivo treatment
Biological: Subcutan implantation of autologus skin graft after ex-vivo treatment
First Posted Date
2012-03-15
Last Posted Date
2016-09-13
Lead Sponsor
Medgenics Medical Israel Ltd.
Target Recruit Count
4
Registration Number
NCT01555515

Safety and Biological Activity of InfraDure Biopump Secreting Sustained Interferon in HCV Patients

Phase 1
Terminated
Conditions
Hepatitis C
Interventions
Biological: implantation
First Posted Date
2011-09-13
Last Posted Date
2016-09-13
Lead Sponsor
Medgenics Medical Israel Ltd.
Target Recruit Count
3
Registration Number
NCT01433133

Safety and Efficacy of Sustained Interferon Alfa 2b (INF) Therapy of Relapsing Hepatitis C (HCV) Patients Using InfraDure Biopump

Phase 1
Withdrawn
Conditions
Hepatitis C
First Posted Date
2011-09-07
Last Posted Date
2014-04-17
Lead Sponsor
Medgenics Medical Israel Ltd.
Registration Number
NCT01430000
Locations
🇮🇱

Prof. Eithan Galun Gene Therapy Institute, Hadassah Medical Center Ein Kerem, Jerusalem, Israel, Jerusalem, Israel

Safety and Efficacy of Sustained Erythropoietin Therapy

Phase 1
Completed
Conditions
Anemia
Interventions
Biological: EPODURE (dermal Biopump for erythropoietin)
First Posted Date
2007-10-11
Last Posted Date
2014-04-17
Lead Sponsor
Medgenics Medical Israel Ltd.
Target Recruit Count
19
Registration Number
NCT00542568
Locations
🇮🇱

Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

🇮🇱

Hadassah Medical Organization, Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath